# Ramipril Capsules RFP

Canonical: https://abierto.us/opportunities/36e79726r0034

- Solicitation number: 36E79726R0034
- Notice type: Presolicitation
- Status: Open. Offers due November 23, 2026 at 3:30 PM EST
- Department: Department of Veterans Affairs
- Contracting office: Nac Pharmaceuticals (36E797)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- Who can bid, by location: Anywhere in the US. Location does not limit who can bid: a product shipped to the buyer, research at the performer's facility, or work at the contractor's site. A state shown is the delivery point.
- First posted: October 29, 2026
- Last posted: October 29, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/dfb4dcac249c49929a568cd556ed5f9d/view

## Description

Page 2 of 2
Page 2 of 2
PRE-SOLICITATION NOTICE:  The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79726R0034 for an unrestricted procurement for Ramipril capsules for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS).  The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items.  The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs.  Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number.  Glass bottles are not acceptable.   Solicitation #Â 36E79726R0034 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 11/16/2026 with a tentative closing dateÂ of 11/30/2026.  The NAICS code for this procurement isÂ 325412.  Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov.  No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted.   Interested offerors are advised to continuously check this URL for any changes to this solicitation.  All responsible sources may submit an offer that if timely received, will be considered.  The point of contact for this procurement isÂ Amber Zavala.  Questions can be e-mailed to:Â amber.zavala@va.gov.

The estimated annual requirements are as follows:
Description                     Size             Estimated Annual Requirements

RAMIPRIL 1.25MG CAP  100/BT  2,930
RAMIPRIL 2.5MG CAP  100/BT  2,498
RAMIPRIL 2.5MG CAP   500/BT  1,611
RAMIPRIL 5MG CAP                       100/BT  6,018
RAMIPRIL 5MG CAP                       500/BT  2,704
RAMIPRIL 10MG CAP                      100/BT  15,956
RAMIPRIL 10MG CAP   500/BT  4,451

## Attachments

- [36E79726R0034_2.docx](https://sam.gov/api/prod/opps/v3/opportunities/resources/files/b672d75e2f5c4eadb317e9996c2a97eb/download)

## Open now in the same industry

8 open in NAICS 325412.

- Sacubitril/Valsartan Tablets (VA-27-00014055) (36E79727R0007), due November 3, 2026 at 3:30 PM EST. https://abierto.us/opportunities/36e79727r0007
- Methylphenidate ER (SPE2D226R0013), due November 6, 2026 at 3:00 PM EST. https://abierto.us/opportunities/spe2d226r0013
- FY27 Lenalidomide BPA (36C26227Q0083), due November 12, 2026 at 1:00 PM EST. https://abierto.us/opportunities/36c26227q0083

## Publications

- October 29, 2026: Presolicitation, due November 23, 2026 at 3:30 PM EST. Notice dfb4dcac249c49929a568cd556ed5f9d. https://sam.gov/workspace/contract/opp/dfb4dcac249c49929a568cd556ed5f9d/view

## Points of contact

- Amber.Zavala@va.gov, Amber Zavala, amber.zavala@va.gov, (708) 786-5245

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/36e79726r0034.
